Advertisement
Research Article| Volume 45, ISSUE 3, 101495, June 2022

Download started.

Ok

Clinical evaluation of meibomian gland dysfunction in patients with keratoconus

      Abstract

      Purpose

      To investigate the association of keratoconus (KC) with meibomian gland dysfunction (MGD) and to describe the epidemiological characteristics of MGD in this disease.

      Methods

      In this observational study, 120 KC patients seen in the Department of Ophthalmology of the Complexo Hospitalario Universitario de Santiago de Compostela and 87 controls were analyzed. The Ocular surface disease index (OSDI) questionnaire was administered and several DED tests and an evaluation of the meibomian glands and lid margin were performed. MGD signs and DED tests were compared between the groups. Symptoms were further analyzed in patients and controls with and without MGD.

      Results

      KC was significantly associated with MGD after adjusting for age and sex [adjusted odds ratio (ORa), 2.40]. The frequency of MGD in KC patients [59 (49.2%) KC patients and 25 (28.7%) controls had MGD] correlated with the severity of KC (r = 0.206) (P = 0.020). Mean OSDI score in KC patients with and without MGD was 31.1 ± 24.1 and 35.2 ± 26.0 (P = 0.326), and 17.2 ± 22.7 and 13.3 ± 14.1 in controls with and without it (P = 0.366). The most common MGD signs coincided in both groups. Staining with fluorescein (P = 0.000) and lissamine green (P = 0.019) was higher in KC patients, but no differences were detected with TBUT (P = 0.116) or the Schirmer test (P = 0.637). Hypersecretory MGD was the most prevalent variant in both groups.

      Conclusions

      MGD and DED are common in KC patients. MGD correlates with the severity of KC and is indistinguishable from MGD in patients without KC. No association was found with symptoms. Patients with KC should be screened for MGD because of its possible clinical implications. Further research is needed to clarify the role of MGD in KC patients.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Contact Lens and Anterior Eye
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

      1. Hashemi, H. Heydarian, S. Hooshmand, E. Saatchi, M. Yekta, A. Aghamirsalim, M. et al. The prevalence and risk factors for keratoconus: a systematic review and meta-analysis. Cornea. 2020; 39: p. 263-70.

        • Hwang S.
        • Lim D.H.
        • Chung T.-Y.
        Prevalence and incidence of keratoconus in South Korea: a nationwide population-based study.
        Am J Ophthalmol. 2018; 192: 56-64
        • Godefrooij D.A.
        • de Wit G.A.
        • Uiterwaal C.S.
        • Imhof S.M.
        • Wisse R.P.L.
        Age-specific incidence and prevalence of keratoconus: a nationwide registration study.
        Am J Ophthalmol. 2017; 175: 169-172
        • Nielsen K.
        • Hjortdal J.
        • Aagaard Nohr E.
        • Ehlers N.
        Incidence and prevalence of keratoconus in Denmark.
        Acta Ophthalmol Scand. 2007; 85: 890-892
        • Assiri A.A.
        • Yousuf B.I.
        • Quantock A.J.
        • Murphy P.J.
        Incidence and severity of keratoconus in Asir province, Saudi Arabia.
        Br J Ophthalmol. 2005; 89: 1403-1406
        • Shetty R.
        • Ghosh A.
        • Lim R.R.
        • Subramani M.
        • Mihir K.
        • Reshma A.R.
        • et al.
        Elevated expression of matrix metalloproteinase-9 and inflammatory cytokines in keratoconus patients is inhibited by cyclosporine A.
        Invest Ophthalmol Vis Sci. 2015; 56: 738-750
        • McMonnies C.W.
        Inflammation and keratoconus.
        Optom Vis Sci. 2015; 92: e35-41
        • Lema I.
        • Brea D.
        • Rodríguez-González R.
        • Díez-Feijoo E.
        • Sobrino T.M.
        Proteomic analysis of the tear film in patients with keratoconus.
        Mol Vis. 2010; 16: 2055-2061
        • Wisse R.P.L.
        • Kuiper J.J.W.
        • Gans R.
        • Imhof S.
        • Radstake T.R.D.J.
        • Van der Lelij A.
        Cytokine expression in keratoconus and its corneal microenvironment: a systematic review.
        Ocul Surf. 2015; 13: 272-283
        • Woodward M.A.
        • Blachley T.S.
        • Stein J.D.
        The association between sociodemographic factors, common systemic diseases, and keratoconus: an analysis of a nationwide health care claims database.
        Ophthalmology. 2016; 123: 457-465.e2
        • Gordon-Shaag A.
        • Millodot M.
        • Shneor E.
        • Liu Y.
        The genetic and environmental factors for keratoconus.
        Biomed Res Int. 2015; 2015: 1-19
        • Millodot M.
        • Shneor E.
        • Albou S.
        • Atlani E.
        • Gordon-Shaag A.
        Prevalence and associated factors of keratoconus in Jerusalem: a cross-sectional study.
        Ophthalmic Epidemiol. 2011; 18: 91-97
        • Balasubramanian S.A.
        • Pye D.C.
        • Willcox M.D.
        Effects of eye rubbing on the levels of protease, protease activity and cytokines in tears: relevance in keratoconus.
        Clin Exp Optom. 2013; 96: 214-218
        • McMonnies C.W.
        Abnormal rubbing and keratectasia.
        Eye Contact Lens. 2007; 33: 265-271
        • Georgiou T.
        • Funnell C.L.
        • Cassels-Brown A.
        • O'Conor R.
        Influence of ethnic origin on the incidence of keratoconus and associated atopic disease in Asians and white patients.
        Eye. 2004; 18: 379-383
        • El-Massry A.
        • Doheim M.F.
        • Iqbal M.
        • Fawzy O.
        • Said O.M.
        • Yousif M.O.
        • et al.
        Association between keratoconus and thyroid gland dysfunction: a cross-sectional case-control study.
        J Refract Surg. 2020; 36: 253-257
        • Pellegrini M.
        • Bernabei F.
        • Friehmann A.
        • Giannaccare G.
        Obstructive sleep apnea and keratoconus: a systematic review and meta-analysis.
        Optom Vis Sci. 2020; 97: 9-14
        • Bawazeer A.M.
        • Hodge W.G.
        • Lorimer B.
        Atopy and keratoconus: a multivariate analysis.
        Br J Ophthalmol. 2000; 84: 834-836
        • Nelson J.D.
        • Shimazaki J.
        • Benitez-del-Castillo J.M.
        • Craig J.P.
        • McCulley J.P.
        • Den S.
        • et al.
        The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee.
        Invest Ophthalmol Vis Sci. 2011; 52: 1930https://doi.org/10.1167/iovs.10-6997b
        • Viso E.
        • Gude F.
        • Rodríguez-Ares M.T.
        The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain.
        Cornea. 2011; 30: 1-6
        • Tong L.
        • Chaurasia S.S.
        • Mehta J.S.
        • Beuerman R.W.
        Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore.
        Invest Ophthalmol Vis Sci. 2010; 51: 3449https://doi.org/10.1167/iovs.09-4445
      2. Siak, J.J. Tong, L. Wong, W.L. Cajucom-Uy, H. Rosman, M. Saw, S.M. et al. Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay Eye Study. Cornea. 2012; 31:1-6.

        • Hashemi H.
        • Rastad H.
        • Emamian M.H.
        • Fotouhi A.
        Meibomian gland dysfunction and its determinants in Iranian adults: a population-based study.
        Cont Lens Anterior Eye. 2017; 40: 213-216
        • Viso E.
        • Rodríguez-Ares M.T.
        • Abelenda D.
        • Oubiña B.
        • Gude F.
        Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain.
        Invest Ophthalmol Vis Sci. 2012; 53: 2601https://doi.org/10.1167/iovs.11-9228
        • Schaumberg D.A.
        • Nichols J.J.
        • Papas E.B.
        • Tong L.
        • Uchino M.
        • Nichols K.K.
        The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for, MGD.
        Invest Ophthalmol Vis Sci. 2011; 52: 1994https://doi.org/10.1167/iovs.10-6997e
        • Mostovoy D.
        • Vinker S.
        • Mimouni M.
        • Goldich Y.
        • Levartovsky S.
        • Kaiserman I.
        The association of keratoconus with blepharitis.
        Clin Exp Optom. 2018; 101: 339-344
        • Mandathara P.S.
        • Stapleton F.J.
        • Kokkinakis J.
        • Willcox M.D.
        Pilot study of corneal sensitivity and its association in keratoconus.
        Cornea. 2017; 36: 163-168
        • Carracedo G.
        • Recchioni A.
        • Alejandre-Alba N.
        • Martin-Gil A.
        • Crooke A.
        • Morote I.-A.
        • et al.
        Signs and symptoms of dry eye in keratoconus patients: a pilot study.
        Curr Eye Res. 2015; 40: 1088-1094
        • Dienes L.
        • Kiss H.J.
        • Perényi K.
        • Nagy Z.Z.
        • Acosta M.C.
        • Gallar J.
        • et al.
        Corneal sensitivity and dry eye symptoms in patients with keratoconus.
        PLoS ONE. 2015; 10: e0141621
        • Dogru M.
        • Karakaya H.
        • Özçetin H.
        • Ertürk H.
        • Yücel A.
        • Özmen A.
        • et al.
        Tear function and ocular surface changes in keratoconus.
        Ophthalmology. 2003; 110: 1110-1118
        • Gomes J.A.P.
        • Santo R.M.
        The impact of dry eye disease treatment on patient satisfaction and quality of life: a review.
        Ocul Surf. 2019; 17: 9-19
        • Uchino M.
        • Schaumberg D.A.
        Dry eye disease: impact on quality of life and vision.
        Curr Ophthalmol Rep. 2013; 1: 51-57
        • Miljanović B.
        • Dana R.
        • Sullivan D.A.
        • Schaumberg D.A.
        Impact of dry eye syndrome on vision-related quality of life.
        Am J Ophthalmol. 2007; 143: 409-415.e2
        • Mohamed Mostafa E.
        • Abdellah M.M.
        • Elhawary A.M.
        • Mounir A.
        Noncontact meibography in patients with keratoconus.
        J Ophthalmol. 2019; 2019: 1-6
        • Wolffsohn J.S.
        • Arita R.
        • Chalmers R.
        • Djalilian A.
        • Dogru M.
        • Dumbleton K.
        • et al.
        TFOS DEWS II diagnostic methodology report.
        Ocul Surf. 2017; 15: 539-574
        • Walt J.
        Ocular Surface Disease Index (OSDI) Administration and scoring manual.
        Allergan, Inc, Irvine, CA2004
        • Rabinowitz Y.S.
        • Rasheed K.
        KISA% index: a quantitative videokeratography algorithm embodying minimal topographic criteria for diagnosing keratoconus.
        J Cataract Refract Surg. 1999; 25: 1327-1335
        • Romero-Jiménez M.
        • Santodomingo-Rubido J.
        • Wolffsohn J.S.
        Keratoconus: a review.
        Cont Lens Anterior Eye. 2010; 33: 157-166
        • Amano S.
        • Inoue K.
        Clinic-based study on meibomian gland dysfunction in Japan.
        Invest Ophthalmol Vis Sci. 2017; 58: 1283https://doi.org/10.1167/iovs.16-21374
        • Bron A.J.
        • Evans V.E.
        • Smith J.A.
        Grading of corneal and conjunctival staining in the context of other dry eye tests.
        Cornea. 2003; 22: 640-650
        • van Bijsterveld O.P.
        Diagnostic tests in the sicca syndrome.
        Arch Ophthalmol. 1969; 82: 10-14
        • Millán A.
        • Viso E.
        • Gude F.
        • Parafita-Fernández A.
        • Moraña N.
        • Rodríguez-Ares M.T.
        Incidence and associated factors of dry eye in a Spanish adult population: 11-year from the the Salnés Eye Study.
        Cornea. 2018; 37: 1527-1534
        • Benítez-del-Castillo J.M.
        • Acosta M.C.
        • Wassfi M.A.
        • Díaz-Valle D.
        • Gegúndez J.A.
        • Fernandez C.
        • et al.
        Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye.
        Invest Ophthalmol Vis Sci. 2007; 48: 173https://doi.org/10.1167/iovs.06-0127
        • Nichols K.K.
        • Nichols J.J.
        • MPH M.S.
        • Mitchell G.L.
        The lack of association between signs and symptoms in patients with dry eye disease.
        Cornea. 2004; 23: 762-770
        • Nien C.J.
        • Paugh J.R.
        • Massei S.
        • Wahlert A.J.
        • Kao W.W.
        • Jester J.V.
        Age-related changes in the meibomian gland.
        Exp Eye Res. 2009; 89: 1021-1027
        • Nien C.J.
        • Massei S.
        • Lin G.
        • Nabavi C.
        • Tao J.
        • Brown D.J.
        • et al.
        Effects of age and dysfunction on human meibomian glands.
        Arch Ophthalmol. 2011; 129: 462-469
      3. Viso, E. Millán, A.C. Rodríguez-Ares, M.T. Rosacea-associated meibomian gland dysfunction - an epidemiological perspective. Eur Ophthalm Revi 2014; 8: p. 13-16.

        • Baudouin C.
        • Messmer E.M.
        • Aragona P.
        • Geerling G.
        • Akova Y.A.
        • Benítez-del-Castillo J.
        • et al.
        Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction.
        Br J Ophthalmol. 2016; 100: 300-306